International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationVariation in the Gross Tumor Volume and Clinical Target Volume for Preoperative Radiotherapy of Primary Large High-Grade Soft Tissue Sarcoma of the Extremity Among RTOG Sarcoma Radiation Oncologists
Introduction
Many studies have shown that the combination of preoperative radiotherapy and surgery is an effective strategy to treat many soft tissue sarcomas (STS) with high-risk features 1, 2, 3, 4, 5, 6. The advantages of preoperative radiation include the delivery of a lower radiation dose to a smaller target volume when compared with postoperative radiotherapy, which translates into fewer chronic side effects (subcutaneous fibrosis, lymphedema, joint stiffness) and better function of the extremity, as suggested by a prospective randomized trial of preoperative vs. postoperative radiotherapy (6). Other potential advantages of preoperative radiotherapy include facilitating surgical resection through tumor shrinkage and reducing the risk of tumor cell seeding at the time of surgery 3, 4, 5. The main concern about preoperative radiotherapy has been centered on the risk of increasing the rate of delayed wound healing 1, 2. In the above-mentioned Phase III prospective study, the rate of major wound complications increased from 17% to 35% with preoperative radiation therapy; these major wound complications were almost entirely limited to the lower extremity and were generally temporary and without significant, long-term effect on function 1, 2.
Traditionally, large fields have been employed for conventional radiotherapy of extremity STS; of note, larger fields are considered to increase the risk for radiation-related toxicity (6). Recently, image-guided radiation treatment (IGRT) technologies such as image-guided intensity modulated radiotherapy (IG-IMRT) have emerged to treat varied malignancies including STS 7, 8, 9, 10, 11. IMRT is able to deliver a highly conformal dose to the gross disease planning target volume and high-risk subclinical disease regions while minimizing dose to selected, adjacent critical structures. It is conceivable that improved techniques of delivering radiotherapy (i.e., IGRT) that conform the high dose region to smaller, more accurately targeted volumes may further reduce radiation related toxicity. Currently, the National Cancer Institute–funded Radiation Therapy Oncology Group (RTOG) is conducting a prospective clinical trial to investigate the impact of preoperative advanced image-guided radiation technology (IGRT) on the risk of radiation-related toxicities in patients with extremity STS. Target volumes such as gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV) are delineated according to strict guidelines in this study. A total dose of 50 Gy in 25 fractions was prescribed to 95% or more primary tumor PTV using either daily image-guided three-dimensional conformal radiotherapy or intensity-modulated radiotherapy. Here we conducted a comparative study of the delineated GTV and CTV in the treatment of extremity STS by multiple sarcoma radiation oncologists who participated in this clinical study looking at the concordance among this group. With this analysis, we aim to demonstrate that it will be possible to develop a consensus of GTV and CTV for future prospective studies of preoperative radiotherapy for STS.
Section snippets
Methods and Materials
This research was reviewed and approved by the Medical College of Wisconsin Human Research Protection Office and all collaborators completed training in both human research and patient privacy at their respective institutions. Treatment planning computed tomography (CT) scans along with the associated diagnostic MR images from two patients with STS who had undergone diagnostic core needle biopsies; one patient had an STS of the upper extremity and the other an STS of lower extremity. The CT
Results
Twelve radiation oncologists who enrolled patients into the current National Cancer Institute/RTOG IGRT sarcoma study (RTOG 0630) were asked to participate; 10 returned contour data sets. Minimal variations in the GTV in both lower extremity and upper extremity cases were seen among the participating physicians; minimal variations were also noted in the lower extremity CTV, but more variability was seen for the upper extremity CTV among the participating physicians, as demonstrated in Fig. 1,
Discussion
In the era of IGRT for extremity STS, it is imperative that the GTV and CTV are accurately defined to implement advanced IGRT successfully, especially IG-IMRT. The successful application of such advanced treatment delivery will potentially maintain high rates of local tumor control while reducing radiation-related toxicities when compared with the traditional “large-field” conventional radiotherapy 6, 11. Results from our study including sarcoma radiation oncologists participating in RTOG
References (16)
- et al.
Multimodality treatment of upper extremity bone and soft tissue sarcomas
Hand Clin
(2004) - et al.
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
Radiother Oncol
(2005) - et al.
Image guidance for precise conformal radiotherapy
Int J Radiat Oncol Biol Phys
(2003) - et al.
Computed tomography guided management of interfractional patient variation
Semin Radiat Oncol
(2005) - et al.
Tomotherapy
Semin Radiat Oncol
(1999) - et al.
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes
Int J Radiat Oncol Biol Phys
(2005) - et al.
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma
J Clin Oncol
(2002) - et al.
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomized trial
Lancet
(2002)
Cited by (0)
This study is supported by ATC Grant U24 CA81647 from the National Institutes of Health.
Conflict of interest: none.